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Letters to the
Editor
Global statistics/outcomes
To the Editor:
The recent article by Ribeiro and associ-
ates1 and the related editorial by David2
merit further comment and discussion.
Clearly, globalization and the Internet,
especially The Cardiothoracic Surgery
Network, have brought the cardiothoracic
surgery community closer together. It was
only a matter of time before the results of
cardiac surgery in developing countries or
emerging economies would be voluntarily
reported. The authors are correct in that the
reports are scanty regarding worldwide re-
sults in cardiac surgery. Yes, we want to
know the global statistics, but there is no
international or national body presently
willing and able to extract and gather this
information, certainly on a voluntary basis.
Small and large programs in these coun-
tries are hesitant to report their results, for
fears both imagined and unimagined.
Rather than go through the evolutionary
torture chamber of the developed coun-
tries’ database and reporting systems, we
should establish a voluntary system that
would offer interested international pro-
grams a system that fixes the problem, and
not the blame. The Northern New England
Cardiovascular Disease Study Group data-
base program is one example to study and
modify for developing/emerging pro-
grams.3 The international database plan of
the European Association for Cardiotho-
racic Surgery was started but, to my knowl-
edge, has not been developed or reported in
recent years.4 Only with an international da-
tabase containing the global number of pro-
grams, surgeons, caseloads, and outcomes
can we even begin to develop logical strate-
gies and offer valid suggestions and recom-
mendations to those programs and countries
that are courageous, honest, and willing to
share their results. At the present time,
global statistics regarding number of pro-
grams, cardiothoracic surgeons, annual ca-
seloads, and results are extracted from oc-
casional reports like this one, the Unger
report,5 personal communications, and cor-
porate privatory information. Hospital vol-
ume is only one variable that should be
looked at. Other variables including age,
complexity, comorbidity, mortality, mor-
bidity, and long-term results are also im-
portant, but surgical training and institu-
tional support facilities, especially with
regard to access to care and waiting lists,
need to be analyzed and addressed as well.
Any recommendations offered must bal-
ance the results in developed and emerging
programs to meet international guidelines
or recommendations, and not standards or
requirements. That will evolve over time.
Let’s get everyone into the boat, going in
the same direction, and then decide who
sits where and who does what! The authors
should be praised for their efforts, and other
groups and centers in emerging economies
or developing countries should be encour-
aged to present similar reports and studies.
A. Thomas Pezzella MD
Director, Special Projects
World Heart Foundation
Attending Cardiothoracic Surgeon
Shanghai Chest Hospital
Shanghai, China
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The effect of aortic valve
replacement on coronary
flow reserve
To the Editor:
We read with great interest and congratu-
late Bakhtiary and colleagues1 on the study
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entitled “Stentless Bioprostheses Improve
Postoperative Coronary Flow More Than
Stented Prostheses After Valve Replace-
ment for Aortic Stenosis.” This intriguing
magnetic resonance imaging study found
that patients receiving stentless valves
showed a normal coronary flow reserve
(CFR) 6 months after aortic valve re-
placement (AVR), whereas those receiv-
ing stented valves demonstrated a slightly
reduced CFR. However, we feel that a few
additional comments are necessary.
In recent echocardiographic studies, re-
duced CFR has been demonstrated in aortic
stenosis (AS) patients regardless of the
presence or absence of coronary artery dis-
ease.2-6 We found a CFR improvement in
AS patients 15 months after AVR with
mechanical valves.4 This CFR improve-
ment paralleled the regression of left ven-
tricular hypertrophy. However, CFR did
not reach normal values, thus suggesting
that other factors also play a role in CFR
impairment in AS. This has been strength-
ened by our more recent findings that CFR
improvement 3 years after AVR was tran-
sient despite unchanged left ventricular
mass.5
Overall, these results suggest that
AVR with mechanical valves is associ-
ated with coronary microvascular func-
tional alterations. Further studies in
larger AS populations are warranted us-
ing more reliable techniques for CFR
evaluation (such as magnetic resonance
imaging) to verify our disappointing long-
term results. Also, potential differences be-
tween different kinds of mechanical valves
and bioprostheses should be investigated to
identify the optimal therapy for coronary
circulation.
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Reply to the Editor:
We appreciate the comments of Nemes and
associates regarding our recent article and
would like to point out the following issues
in response to their comments.
The current published clinical trial fol-
lowed our previous animal studies,1,2 in
which we investigated the effects of valve
design and orientation on acute changes of
coronary flow in different mechanical valve
substitutes and the native aortic valve. In the
group in which we did not replace the aortic
valve but only performed 90 minutes of ex-
tracorporeal circulation and 60 minutes of
myocardial ischemia, coronary flow rates in-
creased significantly. No mechanical aortic
valve could achieve this reactive hyperemia,
with superior results for the Medtronic Hall
and Advantage valves compared with the St
Jude standard bileaflet valve. Coronary flow
rates depended not only on valve design, but
also on valve orientation; the previously de-
fined optimal orientations with respect to
hemodynamics also provided the highest
coronary artery flow. We explained these
findings by lower intraventricular diastolic
pressures and reduced levels of aortic root
turbulence in the optimal orientations.
In the recent study, our patients had no
history of coronary artery disease, but angina
pectoris was present in more than 50%. The
improvement of coronary flow reserve (CFR)
in the stentless group was independent of the
left ventricular mass regression. However,
we observed a trend toward accelerated
regression of left ventricular mass regres-
sion in the stentless group, without any
statistical significance (P  .06).
We share the opinion that aortic valve
design has a significant influence on improve-
ment of CFR after prosthetic aortic valve re-
placement. The increased long-term mortality
described in recent studies in patients with
severe aortic valve disease after aortic valve
replacement3,4 compared with the normal
population could be partially caused by these
findings. Therefore, CFR should be included
if in vivo hemodynamic performance of pros-
thetic aortic valves is investigated.
Regarding the optimal clinical method
for measurement of CFR, we agree with
Nemes and colleagues that magnetic reso-
nance imaging can provide more objective
results compared with echocardiography;
conversely, the echocardiography method
is less complex and easier to perform. We
have just completed a retrospective study
on 20 aortic valve patients (Advantage,
n  10; St Jude Medical, n  10; interval
from the operation, 6 months). Echocar-
diographic measurement of CFR (adeno-
sine 140 g · kg1 · min1 over 7 minutes)
was possible in 17 patients (85%). Normal
CFR was demonstrated in only three Ad-
vantage patients (Table 1). Because this
was not a randomized study, we have not
yet published these data, but we have initi-
ated a randomized clinical multicenter study
with echocardiographic measurement of
CFR between the two bileaflet mechanical
valve substitutes with large patient numbers
to investigate chronic changes of CFR after
mechanical aortic valve replacement.
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